Healthcare -
Biotechnology - NASDAQ - US
$ 4.39
-1.84 %
$ 37.9 M
Market Cap
-0.36
P/E
KPTI - GROSS PROFIT
Gross Profit KPTI - Karyopharm Therapeutics Inc.
139 M
LAST VALUE
-4.25%
2 YEAR CAGR
29.33%
5 YEAR CAGR
15.77%
10 YEAR CAGR